<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2025-5962</article-id><article-id custom-type="edn" pub-id-type="custom">OJUAKA</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-5962</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ПРОБЛЕМНАЯ СТАТЬЯ</subject></subj-group></article-categories><title-group><article-title>Кардиоренальные взаимосвязи у лиц с различными нозологическими формами кардиомиопатий</article-title><trans-title-group xml:lang="en"><trans-title>Cardiorenal relationships in individuals with various cardiomyopathies</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1568-9993</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Медведенко</surname><given-names>И. В</given-names></name><name name-style="western" xml:lang="en"><surname>Medvedenko</surname><given-names>I. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Медведенко Игорь В. — врач-кардиолог, соискатель кафедры клинической фармакологии и терапии ИДПО</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">iga_rexa@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-4526-8652</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Вардугина</surname><given-names>Н. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Vardugina</surname><given-names>N. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Вардугина Надежда Георгиевна — д.м.н., профессор кафедры клинической фармакологии и терапии</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">centrproff@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5129-1651</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Маркина</surname><given-names>Н. В</given-names></name><name name-style="western" xml:lang="en"><surname>Markina</surname><given-names>N. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Маркина Нэлли В. — к.т.н., доцент, зав. кафедрой математики, медицинской информатики, информатики и статистики, физики</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">markina.nel@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0962-8980</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кузин</surname><given-names>А. И</given-names></name><name name-style="western" xml:lang="en"><surname>Kuzin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Кузин Анатолий И. — д.м.н., профессор, зав. кафедрой клинической фармакологии и терапии ИДПО</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">aikq74@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-1276-1796</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Резвушкина</surname><given-names>Е. А</given-names></name><name name-style="western" xml:lang="en"><surname>Rezvushkina</surname><given-names>E. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Резвушкина Екатерина А. — врач-кардиолог, лаборант кафедры клинической фармакологии и терапии ИДПО</p><p>Челябинск</p></bio><bio xml:lang="en"><p>Chelyabinsk</p></bio><email xlink:type="simple">kash7503@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Южно-Уральский государственный медицинский университет Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>South Ural State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2025</year></pub-date><pub-date pub-type="epub"><day>20</day><month>05</month><year>2025</year></pub-date><volume>30</volume><issue>4</issue><fpage>5962</fpage><lpage>5962</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Медведенко И.В., Вардугина Н.Г., Маркина Н.В., Кузин А.И., Резвушкина Е.А., 2025</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="ru">Медведенко И.В., Вардугина Н.Г., Маркина Н.В., Кузин А.И., Резвушкина Е.А.</copyright-holder><copyright-holder xml:lang="en">Medvedenko I.V., Vardugina N.G., Markina N.V., Kuzin A.I., Rezvushkina E.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/5962">https://russjcardiol.elpub.ru/jour/article/view/5962</self-uri><abstract><sec><title>Цель</title><p>Цель. Выявить кардиоренальные взаимосвязи и их особенности у лиц с различными нозологическими формами кардиомиопатий (КМП).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Проведён анализ 267 пациентов с КМП, из них мужчин было 204 (76,4%) человека. В перечень КМП вошли дилатационная КМП (ДКМП), гипертрофическая КМП (ГКМП), алкогольная (АКМП), ишемическая КМП (ИКМП) и воспалительная КМП (ВКМП). Оценивались взаимосвязи скорости клубочковой фильтрации (СКФ) с формами КМП и параметрами эхокардиографии (ЭхоКГ): фракция выброса (ФВ), конечный систолический и конечный диастолический размер левого желудочка (КСР и КДР), толщина стенок левого желудочка (ТСЛЖ), правый желудочек (ПЖ), левое и правое предсердия.</p></sec><sec><title>Результаты</title><p>Результаты. Среди лиц с КМП найдено значимое снижение СКФ при ДКМП, ИКМП и ГКМП. У мужчин имелась положительная связь СКФ с ФВ и отрицательная связь СКФ с КСР при ДКМП (r=0,317, р=0,012 и r=-0,269, р=0,036) и при ИКМП (r=0,359, p=0,017 и r=-0,660, р=0,007). У женщин взаимосвязей СКФ с ФВ не получено. У женщин с ДКМП выявлена сильная положительная связь СКФ с ТСЛЖ (r=0,894, p=0,041). При ИКМП у женщин найдена отрицательная связь СКФ с ПЖ (r=-0,650, р=0,003) и КСР (r=-0,829, р=0,042). У женщин с ДКМП и ИКМП в регрессионные уравнения с зависимой переменной СКФ вошёл только параметр ПЖ, тогда как у мужчин — все параметры ЭхоКГ. В общей группе ГКМП была отрицательная корреляция СКФ с ТСЛЖ (r=-0,571, р=0,021). В группе ВКМП отрицательная взаимосвязь СКФ с КДР зарегистрирована у молодых мужчин (r=-0,520, р=0,027) и у молодых женщин (r=-0,750, p=0,05).</p></sec><sec><title>Заключение</title><p>Заключение. У лиц с ДКМП, ИКМП и ГКМП наблюдается снижение СКФ в сравнении с АКМП и ВКМП в соответствующем возрасте. У мужчин с ДКМП и ИКМП регистрируется положительная корреляция СКФ с ФВ, а у женщин с ИКМП — отрицательная связь СКФ с ПЖ. Следовательно, гендерные особенности взаимосвязей СКФ с параметрами ЭхоКГ у мужчин и женщин отражают ту или иную адаптивную модель перестройки сердечно-сосудистой системы при КМП. Ремоделирование миокарда левого желудочка при КМП в виде утолщения или истончения ассоциируется со снижением СКФ как у мужчин, так и у женщин.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To identify cardiorenal relationships and related characteristics in individuals with various cardiomyopathies.</p></sec><sec><title>Material and methods</title><p>Material and methods. An analysis of 267 patients with cardiomyopathy (CMP) was conducted, of which 204 (76,4%) were men. There were dilated CMP (DCM), hypertrophic CMP (HCM), alcoholic (ACM), ischemic CMP (ICM) and inflammatory CMP (InCM). We assessed the relationships between glomerular filtration rate (GFR) and CMP forms and following echocardiography parameters: ejection fraction (EF), left ventricular (LV) end-systolic (ESD) and end-diastolic dimensions (EDD), left ventricular wall thickness (LVWT), right ventricle (RV), left and right atria.</p></sec><sec><title>Results</title><p>Results. Among individuals with CMP, a significant decrease in GFR was found in DCM, ICM, and HCM. In men, there was a positive relationship between GFR and EF and a negative relationship between GFR and ESD in DCM (r=0,317, p=0,012 and r=-0,269, p=0,036) and ICM (r=0,359, p=0,017 and r=-0,660, p=0,007). In women, no relationships between GFR and EF were found. In women with DCM, a strong positive relationship between GFR and LVWT (r=0,894, p=0,041) was found. In women with ICM, a negative relationship between GFR and RV (r=-0,650, p=0,003) and ESD (r=-0,829, p=0,042) was found. In women with DCM and ICM, only the RV parameter was included in the regression equations with the dependent variable GFR, while in men, all echocardiography parameters were included. In the general HCM group, there was a negative correlation between GFR and LVWT (r=-0,571, p=0,021). In the HCM group, a negative relationship between GFR and EDD was recorded in young men (r=-0,520, p=0,027) and in young women (r=-0,750, p=0,05).</p></sec><sec><title>Conclusion</title><p>Conclusion. In individuals with DCM, ICM, and HCM, a decrease in GFR is observed compared to ACM and InCM at the corresponding age. In men with DCM and ICM, a positive correlation of GFR with EF is recorded, and in women with ICM, a negative relationship of GFR with RV. Therefore, sex-specific relationships between GFR and echocardiography parameters in men and women reflect one or another adaptive model of cardiovascular remodeling in CMP. Left ventricular remodeling in CMP with thickening or thinning is associated with a decrease in GFR in both men and women.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>кардиомиопатии</kwd><kwd>скорость клубочковой фильтрации</kwd><kwd>эхокардиография</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cardiomyopathy</kwd><kwd>glomerular filtration rate</kwd><kwd>echocardiography</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Резник Е.В., Никитин И.Г. Кардиоренальный синдром у больных с сердечной недостаточностью как этап кардиоренального континуума (часть I): определение, классификация, патогенез, диагностика, эпидемиология (обзор литературы). Архивъ внутренней медицины. 2019;9(1):5-22. doi:10.20514/2226-6704-2019-9-1-5-22.</mixed-citation><mixed-citation xml:lang="en">Reznik EV, Nikitin IG. Cardiorenal syndrome in patients with chronic heart failure as a stage of the cardiorenal continuum (part I): definition, classification, pathogenesis, diagnosis, epidemiology. The Russian Archives of Internal Medicine. 2019;9(1):5-22. (In Russ.) doi:10.20514/2226-6704-2019-9-1-5-22.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Кудина Е.В., Ларина В.Н., Шерегова Е.Н. Хроническая болезнь почек в структуре сердечно-сосудистой коморбидности: в помощь врачу первичного звена. Международный журнал сердца и сосудистых заболеваний. 2021;9(29):27-37.</mixed-citation><mixed-citation xml:lang="en">Kudina EV, Larina VN, Sheregova EN. Managing patients with chronic kidney disease and cardiovascular comorbidities in primary care. International Journal of Heart and Vascular Diseases. 2021;9(29):27-37. (In Russ.)</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Patel N, Yaqoob MM, Aksentijevic D. Cardiac metabolic remodelling in chronic kidney disease. Nat Rev Nephrol. 2022;18(8):524-37. doi:10.1038/s41581-022-00576-x.</mixed-citation><mixed-citation xml:lang="en">Patel N, Yaqoob MM, Aksentijevic D. Cardiac metabolic remodelling in chronic kidney disease. Nat Rev Nephrol. 2022;18(8):524-37. doi:10.1038/s41581-022-00576-x.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Law JP, Pickup L, Pavlovic D, et al. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. J Hum Hypertens. 2023;37(1):1-19. doi:10.1038/s41371-022-00751-4.</mixed-citation><mixed-citation xml:lang="en">Law JP, Pickup L, Pavlovic D, et al. Hypertension and cardiomyopathy associated with chronic kidney disease: epidemiology, pathogenesis and treatment considerations. J Hum Hypertens. 2023;37(1):1-19. doi:10.1038/s41371-022-00751-4.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Romero-González G, González A, López B, et al. Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis. Nephrol Dial Transplant. 2022;37(5):817-24. doi:10.1093/ndt/gfaa284.</mixed-citation><mixed-citation xml:lang="en">Romero-González G, González A, López B, et al. Heart failure in chronic kidney disease: the emerging role of myocardial fibrosis. Nephrol Dial Transplant. 2022;37(5):817-24. doi:10.1093/ndt/gfaa284.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hulshoff MS, Rath SK, Xu X, et al. Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis. Semin Nephrol. 2018;38(6):629-36. doi:10.1016/j.semnephrol.2018.08.007.</mixed-citation><mixed-citation xml:lang="en">Hulshoff MS, Rath SK, Xu X, et al. Causal Connections From Chronic Kidney Disease to Cardiac Fibrosis. Semin Nephrol. 2018;38(6):629-36. doi:10.1016/j.semnephrol.2018.08.007.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schlingmann KP, Jouret F, Shen K, et al. mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy. J Am Soc Nephrol. 2021; 32(11):2885-99. doi:10.1681/ASN.2021030333.</mixed-citation><mixed-citation xml:lang="en">Schlingmann KP, Jouret F, Shen K, et al. mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy. J Am Soc Nephrol. 2021; 32(11):2885-99. doi:10.1681/ASN.2021030333.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Yang L, Chen Y, Huang W. What Links Chronic Kidney Disease and Ischemic Cardiomyopathy? A Comprehensive Bioinformatic Analysis Utilizing Bulk and Single-Cell RNA Sequencing Data with Machine Learning. Life (Basel). 2023;13(11):2215. doi:10.3390/life13112215.</mixed-citation><mixed-citation xml:lang="en">Yang L, Chen Y, Huang W. What Links Chronic Kidney Disease and Ischemic Cardiomyopathy? A Comprehensive Bioinformatic Analysis Utilizing Bulk and Single-Cell RNA Sequencing Data with Machine Learning. Life (Basel). 2023;13(11):2215. doi:10.3390/life13112215.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Valbuena-López SC, Camastra G, Cacciotti L, et al. Cardiac Imaging Biomarkers in Chronic Kidney Disease. Biomolecules. 2023;13(5):773. doi:10.3390/biom13050773.</mixed-citation><mixed-citation xml:lang="en">Valbuena-López SC, Camastra G, Cacciotti L, et al. Cardiac Imaging Biomarkers in Chronic Kidney Disease. Biomolecules. 2023;13(5):773. doi:10.3390/biom13050773.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Вардугина Н.Г., Медведенко И.В., Ефимова Н.М. Кардиомиопатии: эхокардиографические профили по данным факторного анализа методом главных компонент у мужчин и женщин. Российский кардиологический журнал. 2020;25(11):4108. doi:10.15829/1560-4071-2020-4108.</mixed-citation><mixed-citation xml:lang="en">Vardugina NG, Medvedenko IV, Efimova NM. Cardiomyopathies: echocardiographic profiles based on principal component factor analysis in men and women. Russian Journal of Cardiology. 2020;25(11):4108. (In Russ.) doi:10.15829/1560-4071-2020-4108.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Богданов Д.В., Шапошник И.И. Варианты клинического течения, исходы и прогноз гипертрофической необструктивной кардиомиопатии — результаты длительного наблюдения. Российский кардиологический журнал. 2019;(11):48-54. doi:10.15829/1560-4071-2019-11-48-54.</mixed-citation><mixed-citation xml:lang="en">Bogdanov DV, Shaposhnik II. Clinical variants, outcomes and prognosis of hypertrophic non-obstructive cardiomyopathy: results of long-term follow-up. Russian Journal of Cardiology. 2019;(11):48-54. (In Russ.) doi:10.15829/1560-4071-2019-11-48-54.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Kadappu KK, Kuncoro AS, Hee L, et al. Chronic kidney disease is independently associated with alterations in left atrial function. Echocardiography. 2014;31(8):956-64. doi:10.1111/echo.12503.</mixed-citation><mixed-citation xml:lang="en">Kadappu KK, Kuncoro AS, Hee L, et al. Chronic kidney disease is independently associated with alterations in left atrial function. Echocardiography. 2014;31(8):956-64. doi:10.1111/echo.12503.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Jameel FA, Junejo AM, Khan Q UlA, et al. Echocardiographic Changes in Chronic Kidney Disease Patients on Maintenance Hemodialysis. Cureus. 2020;12(7):e8969. doi:10.7759/cureus.8969.</mixed-citation><mixed-citation xml:lang="en">Jameel FA, Junejo AM, Khan Q UlA, et al. Echocardiographic Changes in Chronic Kidney Disease Patients on Maintenance Hemodialysis. Cureus. 2020;12(7):e8969. doi:10.7759/cureus.8969.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Kadappu KK, Abhayaratna K, Boyd A, et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume. J Am Soc Echocardiogr. 2016;29(4):359-67. doi:10.1016/j.echo.2015.11.019.</mixed-citation><mixed-citation xml:lang="en">Kadappu KK, Abhayaratna K, Boyd A, et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic Kidney Disease: The Value of Left Atrial Function and Volume. J Am Soc Echocardiogr. 2016;29(4):359-67. doi:10.1016/j.echo.2015.11.019.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Ureche C, Dodi G, Covic A, et al. Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients. J Clin Med. 2023;12(8):3003. doi:10.3390/jcm12083003.</mixed-citation><mixed-citation xml:lang="en">Ureche C, Dodi G, Covic A, et al. Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients. J Clin Med. 2023;12(8):3003. doi:10.3390/jcm12083003.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
